Costly treatments for rheumatoid arthritis, multiple sclerosis, cancer, and, especially, hepatitis C are expected to drive unprecedented growth in U.S. spending on specialty drugs in the next two years. Some analysts say that’s not good news for consumers or most pharmacists.
Express Scripts noted in its recently released Drug Trend Report that the 2013 growth in specialty drug spending had reached 14.1%. However, costs associated with specialty drug spending are expected to skyrocket 63% between 2014 and 2016, the report stated.
Less than 1% of all U.S. prescriptions are for specialty medications. However, specialty drug spending makes up 27.7% of the country’s total pharmacy spend, the report said.
Alabama Pharmacist Defense Lawyer, Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney